17β-ヒドロキシステロイド脱水素酵素
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
Japanese Journal
- 大豆イソフラボンによる肺がんリスク軽減効果の性差発現機序の解明 (第17回研究報告会記録)
- Synthesis of a Human Urate Transporter-1 Inhibitor, an Arginine Vasopressin Antagonist, and a 17β-Hydroxysteroid Dehydrogenase Type-3 Inhibitor, Using Ring-Expansion of Cyclic Ketoximes with DIBALH
- Synthesis of a Human Urate Transporter-1 Inhibitor, an Arginine Vasopressin Antagonist, and a 17β-Hydroxysteroid Dehydrogenase Type-3 Inhibitor, Using Ring-Expansion of Cyclic Ketoximes with DIBALH
Related Links
- 17β-hydroxysteroid dehydrogenase type 10 (HSD10) deficiency is a disorder that affects many parts of the body. This condition is typically more severe in males than in females. Males with HSD10 deficiency have normal ...
- Prevalence In the Netherlands, 17-beta-hydroxysteroid dehydrogenase III deficiency is estimated to occur in 1:147,000 newborns. [2] Clinical characteristics 17-beta-hydroxysteroid dehydrogenase III deficiency is clinically ...
★リンクテーブル★
[★]
- 英
- 17β-hydroxysteroid dehydrogenase 17β-HSD
- 関
- ステロイド
[★]
水酸化ステロイド脱水素酵素、ヒドロキシステロイド脱水素酵素、水酸化ステロイドデヒドロゲナーゼ、ヒドロキシステロイドデヒドロゲナーゼ
- 関
- HSD
[★]
脱水素酵素 デヒドロゲナーゼ
[★]
脱水素酵素 デヒドロゲナーゼ